The Lymphomas

por Hoskin, P J
Publicado 1998

The changing role of radiation therapy in the management of oligometastatic disease

por Tharmalingham, H., Hoskin, P.J.
Publicado 2017

Morphine: pharmacokinetics and clinical practice.

por Hoskin, P. J., Hanks, G. W.
Publicado 1990

Pain Control in Advanced Cancer: Pharmacological Methods

por Hanks, G. W., Hoskin, P. J.
Publicado 1986

What is the role of radiation-chemotherapy in the radical non-surgical management of carcinoma of the oesophagus? Upper GI Cancer Working Party of the UK Medical Research Council.

por Price, P., Hoskin, P. J., Hutchinson, T., Stenning, S.
Publicado 1998

Practical brachytherapy solutions to an age-old quandary

por Thiruthaneeswaran, N., Tharmalingam, H., Hoskin, P.J.
Publicado 2020

GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON

por Hoskin, P J, Sibtain, A, Daley, F M, Wilson, G D
Publicado 2003

Analgesics in cancer pain: current practice and beliefs.

por White, I. D., Hoskin, P. J., Hanks, G. W., Bliss, J. M.
Publicado 1991

Long-term follow-up of patients treated with radiotherapy alone for early-stage histologically aggressive non-Hodgkin's lymphoma

por Spicer, J, Smith, P, Maclennan, K, Hoskin, P, Hancock, B, Linch, D, Pettengell, R
Publicado 2004

Clinical Guidance for the Management of Patients with Urothelial Cancers During the COVID-19 Pandemic – Rapid Review

por Patel, K., Choudhury, A., Hoskin, P., Varughese, M., James, N., Huddart, R., Birtle, A.
Publicado 2020

Nicotinamide pharmacokinetics in humans: effect of gastric acid inhibition, comparison of rectal vs oral administration and the use of saliva for drug monitoring.

por Stratford, M. R., Dennis, M. F., Hoskin, P., Phillips, H., Hodgkiss, R. J., Rojas, A.
Publicado 1996

Effects of impaired renal function on the pharmacokinetics of raltitrexed (Tomudex ZD1694).

por Judson, I., Maughan, T., Beale, P., Primrose, J., Hoskin, P., Hanwell, J., Berry, C., Walker, M., Sutcliffe, F.
Publicado 1998

Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy.

por Hoskin, P. J., Saunders, M. I., Phillips, H., Cladd, H., Powell, M. E., Goodchild, K., Stratford, M. R., Rojas, A.
Publicado 1997

Expression of miR-210 in relation to other measures of hypoxia and prediction of benefit from hypoxia modification in patients with bladder cancer

por Irlam-Jones, J J, Eustace, A, Denley, H, Choudhury, A, Harris, A L, Hoskin, P J, West, C M L
Publicado 2016

Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non-small-cell lung cancer.

por Saunders, M. I., Rojas, A., Lyn, B. E., Pigott, K., Powell, M., Goodchild, K., Hoskin, P. J., Phillips, H., Verma, N.
Publicado 1998

A practical approach to bladder preservation with hypofractionated radiotherapy for localised muscle-invasive bladder cancer

por Portner, R., Bajaj, A., Elumalai, T., Huddart, R., Murthy, V., Nightingale, H., Patel, K., Sargos, P., Song, Y., Hoskin, P., Choudhury, A.
Publicado 2021

Enhanced stability of microRNA expression facilitates classification of FFPE tumour samples exhibiting near total mRNA degradation

por Hall, J S, Taylor, J, Valentine, H R, Irlam, J J, Eustace, A, Hoskin, P J, Miller, C J, West, C M L
Publicado 2012

Expression of hypoxia-inducible factor-1α predicts benefit from hypoxia modification in invasive bladder cancer

por Hunter, B A, Eustace, A, Irlam, J J, Valentine, H R, Denley, H, Oguejiofor, K K, Swindell, R, Hoskin, P J, Choudhury, A, West, C M
Publicado 2014

A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma

por Burton, C, Linch, D, Hoskin, P, Milligan, D, Dyer, M J S, Hancock, B, Mouncey, P, Smith, P, Qian, W, MacLennan, K, Jack, A, Webb, A, Cunningham, D
Publicado 2006

High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/A...

por Harrison, C N, Gregory, W, Hudson, G Vaughan, Devereux, S, Goldstone, A H, Hancock, B, Winfield, D, MacMillan, A K, Hoskin, P, Newland, A C, Milligan, D, Linch, D C
Publicado 1999